Focused on sustaining operational, financial performance in near-term: Jubilant Life Sciences

The company posted a total revenue from operations of Rs 9,154.4 crore in FY20, up 0.5 per cent year-on-year, with international revenue of Rs 7,124 crore contributing 78 per cent to the total revenue, its annual report for fiscal year 2019-20 said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2YmXnxe
via IFTTT